Efficacy of Combined Use of Everolimus and Second-Generation Pan-EGRF Inhibitors in KRAS Mutant Non-Small Cell Lung Cancer Cell Lines.
Renato José da Silva-OliveiraIzabela Natalia Faria GomesLuciane Sussuchi da SilvaAndré van Helvoort LengertAna Carolina LausMatias Eliseo MelendezCarla Carolina MunariFernanda de Paula CuryGiovanna Barbarini LongatoRui Manuel Vieira ReisPublished in: International journal of molecular sciences (2022)
mutant NSCLC cell lines.